Signaling pathways
-
BA5463 GLPG2938Summary: GLPG2938 is a potent and selective antagonist. - BA5464 CRT0273750Summary: CRT0273750 is a lead compound for ATX inhibitors and modulates plasma LPA levels.
- BA5465 CenerimodSummary: Cenerimod (ACT-334441) is a potent, selective and orally active receptor modulator.
- BA5466 Radioprotectin-1Summary: Radioprotectin-1 is a highly potent and specific lysophosphatidic acid receptor 2 agonist.
- BA5467 ASP-4058Summary: ASP-4058 is a selective, orally active, second generation agonist of sphingosine phosphate receptors 1 and 5.
- BA5468 ONO-9780307Summary: ONO-9780307 is a specific (lysophosphatidicacidreceptor1) antagonist.
- BA5469 ONO-0740556Summary: ONO-0740556 is a potent Gi-coupled human lysophosphatidic acid receptor 1 (LPA1) agonist.
- BA5470 RP101988Summary: RP101442 is the major active metabolite of Ozanimod.
- BA5471 TAK-615Summary: TAK-615 is a negative alteration modulator (NAM) of the receptor used to study pulmonary fibrosis.
- BA5472 ASP6432Summary: ASP6432 is a potent and selective type 1 lysophosphatidic acid receptor antagonist.